Pharmacy
Any such requirement would raise significant legal issues, including First Amendment concerns, PhRMA says.
Whether consumers will benefit from clout, data, lower pricing or not is up for debate.
Aetna's divestiture of Medicare Part D prescription drug plans to WellCare would fully resolve DOJ concerns.
Insurer's pharmacy benefits business OptumRx will take over Genoa, which specializes in behavioral health and addiction treatment.
The Patient Right to Know Drug Prices Act and the Know the Lowest Price Act are expected to get President Trump's signature.
Hospitals and health systems should adopt better strategies to ensure physicians and nurses don't shift pills to the black market.
Patients would be steered away from their physicians, Association of American Physicians and Surgeons said in letter to AG Jeff Sessions.
Here's a look at what Mayo achieved and what goes into such an agreement with patients.
The antitrust concern over the Medicare prescription drug plans is holding up approval of the $69 billion deal.
PBMs have been dogged by controversy for years, and yet they've become a fixture -- which David Henka sees as a real problem.